Krystal Biotech, Inc. Common Stock
$KRYS
Public valuation for Krystal Biotech, Inc. Common Stock (KRYS). Fair value, signal, and key metrics — no sign-in required.
Current Price
$359.36
Fairly Valued
Fair Value Estimate
$343
🌱
Growth Stage
Fast-growing but still investing heavily in growth
Analyst Consensus
Target: $385.00
7% higher than current
Key Metrics
Market Cap
$10.6B
Forward P/E
43.1x
Operating Margin
49.0%
Revenue Growth
24.4%
PEG Ratio
0.78
Get free watchlist alerts
Join the waitlist for valuation updates on $KRYS and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.